SEC Form 4 · accession 0001209191-18-029241
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vicente Anido Jr.
Officer — Chief Executive Officer · Director
Period of report
Feb 23, 2018
Accepted (ET)
May 10, 2018 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2018 | F | 1,052 | $53.85 | D | 129,725 | D | |
| Common Stock | Feb 24, 2018 | F | 2,054 | $53.85 | D | 127,671 | D | |
| Common Stock | Feb 25, 2018 | F | 1,351 | $53.85 | D | 126,320 | D |
Table II — derivative securities
No Table II lines on this filing.